Alpha 2.0
Login Register
» Authors » Vincent Chow

Vincent Chow

Explore the profile of Vincent Chow including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 88
Citations 721
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Pharmacology
Top 10 Co-Authors
Leonard Kritharides
Austin Chin Chwan Ng
David Brieger
Austin C C Ng
Jerrett K Lau
Tommy Chung
Karice Hyun
Richard Markus
Vladimir Hanes
Andy Sze Chiang Yong
Published In
Int J Cardiol
Heart Lung Circ
PLoS One
Clin Pharmacol Drug Dev
Cancer Chemother Pharmacol
Affiliations
Soon will be listed here.
Recent Articles
1.
Discordance Between Triglycerides, Remnant Cholesterol and Systemic Inflammation in Patients with Schizophrenia
Wang J, Kockx M, Pennings G, Lambert T, Chow V, Kritharides L
Biomedicines . 2025 Jan; 12(12. PMID: 39767790
Background/objectives: Hypertriglyceridaemia and systemic inflammation are prevalent in patients with schizophrenia and contribute to an increased risk of cardiovascular disease. Although elevated triglycerides (TGs) and remnant cholesterol are linked to...
2.
Atrial fibrillation status and associations with adverse clinical outcomes in patients hospitalised with COVID-19: a large unselected statewide population-linkage study
Ne J, Chow C, Chow V, Hyun K, Kritharides L, Brieger D, et al.
Eur Heart J Qual Care Clin Outcomes . 2025 Jan; PMID: 39749838
Background: Atrial fibrillation (AF) is common in COVID-19 patients. The impact of AF on major-adverse-cardiovascular-events (MACE defined as all-cause mortality, myocardial infarction, ischemic stroke, cardiac failure or coronary revascularisation), recurrent...
3.
CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies
Giri S, Harmon C, Hess D, Cespedes Feliciano E, Fumagalli I, Caan B, et al.
J Cachexia Sarcopenia Muscle . 2024 Dec; 16(1):e13664. PMID: 39711205
Background: Older adults with cancer are at an increased risk of treatment related toxicities and early death. Routinely collected clinico-demographic characteristics inadequately explain this increased risk limiting accurate prognostication. Prior...
4.
Changing Epidemiology of Myocarditis in Australia: A Population-Based Cohort Study
Kwan T, Kwan G, Brieger D, Kritharides L, Chow V, Ng A
J Clin Med . 2024 Dec; 13(23). PMID: 39685570
: Myocarditis is a serious disease that has drawn increasing attention due to its association with COVID-19 and vaccination. This study investigates the epidemiology of myocarditis beyond the COVID-19 pandemic,...
5.
Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
Seo N, Kuhns S, Andrews D, Colbert A, Chow V, Liu J
Ophthalmol Ther . 2024 Nov; 14(1):85-101. PMID: 39503991
Introduction: ABP 938 is being developed as a biosimilar to Eylea (aflibercept reference product [RP]), an anti-vascular endothelial growth factor (VEGF) drug used in the management of retinal diseases. Previously,...
6.
Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded, active-controlled, comparative clinical study over 52 weeks
Blauvelt A, Papp K, Trivedi M, Barragan C, Chow V, Mytych D, et al.
Br J Dermatol . 2024 Oct; PMID: 39442018
Background: ABP 654 is a biosimilar to ustekinumab reference product (RP). ABP 654 has been shown to have an amino acid sequence identical to ustekinumab RP and they are similar...
7.
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
Kulasekararaj A, Lanza F, Arvanitakis A, Langemeijer S, Chonat S, Tombak A, et al.
Am J Hematol . 2024 Aug; 99(11):2108-2117. PMID: 39171864
ABP 959 is a biosimilar to the eculizumab reference product (RP), which is approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). This multicenter, randomized, double-blind, active-controlled, two-period...
8.
Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia
Wang J, Kockx M, Bolek M, Lambert T, Sullivan D, Chow V, et al.
J Lipid Res . 2024 Jun; 65(7):100577. PMID: 38879166
Patients with schizophrenia show a disproportionally increased risk of cardiovascular disease. Hypertriglyceridemia is prevalent in this population; however, how this relates to levels of remnant cholesterol, triglyceride (TG)-rich lipoprotein (TRL)...
9.
Morbidity and mortality outcomes of patients requiring isolated tricuspid valve surgery: a retrospective cohort study of 537 patients in New South Wales between 2002 and 2018
Harvey G, Chow V, Rubenis I, Brieger D, Kritharides L, Ng A
BMJ Open . 2024 May; 14(5):e080804. PMID: 38719314
Objectives: The aim of the study was to evaluate mortality and morbidity outcomes following open-heart isolated tricuspid valve surgery (TVSx) with medium to long-term follow-up. Design: Retrospective cohort study. Setting:...
10.
Automated CT Analysis of Body Composition as a Frailty Biomarker in Abdominal Surgery
Fumagalli I, Le S, Peng P, Kipnis P, Liu V, Caan B, et al.
JAMA Surg . 2024 Apr; 159(7):766-774. PMID: 38598191
Importance: Prior studies demonstrated consistent associations of low skeletal muscle mass assessed on surgical planning scans with postoperative morbidity and mortality. The increasing availability of imaging artificial intelligence enables development...